Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 3.0B | 2.7B | 3.0B |
Cost of revenue | 2.3B | 2.7B | 2.4B | 2.5B |
Gross profit | 394M | 321M | 322M | 432M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 246M | 234M | 252M | 255M |
Other operating expenses | — | — | — | -1M |
Operating income | 148M | 96M | 70M | 178M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 28M | 27M | 23M | 24M |
Other income expense | 67M | 62M | 65M | 62M |
Pretax income | 187M | 131M | 112M | 216M |
Tax provision | 38M | 8M | 11M | 43M |
Net income | 149M | 123M | 101M | 173M |
Basic EPS | 3.8 | 3.2 | 2.6 | 4.4 |
Diluted EPS | 3.8 | 3.2 | 2.6 | 4.4 |
Basic average shares | 39.3M | 39.1M | 39.5M | 39.5M |
Diluted average shares | 39.3M | 39.1M | 39.5M | 39.5M |
EBITDA | 294M | 228M | 205M | 309M |
Net income from continuing op. | 149M | 123M | 101M | 173M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |